Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases
Authors:
- Hannes NeuwirtHNHannes Neuwirt
- Martin PuhrMPMartin Puhr
- Frédéric R. SanterFSFrédéric R. Santer
- Martin SusaniMSMartin Susani
- Wolfgang DopplerWDWolfgang Doppler
- Gemma MarciasGMGemma Marcias
- Veronika RauchVRVeronika Rauch
- Maria BruggerMBMaria Brugger
- Alfred HobischAHAlfred Hobisch
- Lukas KennerLukas Kenner
- Zoran CuligZCZoran Culig
Open Access
- 31 May 2009
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 174 (5) , 1921-1930
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1Proceedings of the National Academy of Sciences, 2008
- Signal transducer and activator of transcription 5A/B in prostate and breast cancersEndocrine-Related Cancer, 2008
- Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activationCarcinogenesis, 2008
- Cell Density–Dependent Increase of Constitutive Signal Transducers and Activators of Transcription 3 Activity in Melanoma Cells Is Mediated by Janus KinasesMolecular Cancer Research, 2007
- Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretionEndocrine-Related Cancer, 2007
- Interleukin‐4 stimulates androgen‐independent growth in LNCaP human prostate cancer cellsThe Prostate, 2007
- Wild‐type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer developmentThe FASEB Journal, 2007
- SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cellsBiochemical and Biophysical Research Communications, 2007
- Signal transducer and activator of transcription‐6 (STAT6) is a constitutively expressed survival factor in human prostate cancerThe Prostate, 2007
- Favorable prognostic value of SOCS2 and IGF-I in breast cancerBMC Cancer, 2007